Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan

被引:41
作者
Christensen, Dale B. [1 ]
Roth, Mary [1 ]
Trygstad, Troy
Byrd, John [2 ]
机构
[1] Univ N Carolina, Sch Pharm, Div Pharmaceut Outcomes & Policy, Chapel Hill, NC 27599 USA
[2] Eli Lilly & Co, US Outcomes Res Div, Indianapolis, IN 46285 USA
关键词
medication therapy management; pharmaceutical care; polypharmacy;
D O I
10.1331/JAPhA.2007.06111
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To assess the feasibility of a pharmacist-based medication therapy management (MTM) service for North Carolina State Health Plan enrollees. Design: Before/after design with two control groups. Setting: Community pharmacies and an ambulatory care clinic in North Carolina serving patients from October 2004 to March 2005. Participants: 67 patients who used a large number of prescription drugs, 10 community/ambulatory care pharmacists, and more than 600 participants from two control groups. Interventions: Pharmacist-conducted MTM reviews for volunteering patients. Main outcome measures: Process measures (type and frequency of drug therapy problems detected and services performed), economic measures (number and cost of medications dispensed), and humanistic measures (patient satisfaction with services). Results: Pharmacists identified an average of 3.6 potential drug therapy problems (PDTPs) per patient at the first visit. The most common PDTP categories were "potential underuse" and "more cost-effective drug available." Pharmacist actions were divided nearly equally between activities that would result in increased and decreased drug use. Pharmacists recommended a drug therapy change in about 50% of patients and contacted the prescriber more than 85% of the time. About 50% of patients with PDTPs had a change in drug therapy. Prescription use during the post-intervention period decreased in both the study and control groups but was statistically significant only among the control groups. No significant differences were observed in patient co-payment or insurer prescription costs. Pharmacists provided the following educational services: medication use (90%), disease management (88%), adherence, and self-care (60%). Survey results indicated that patients highly valued the service. Conclusion: A voluntary MTM program targeted at ambulatory patients using a large number of medications reduced the number of PDTPs but did not necessarily result in reductions in prescription drug use or cost. Nearly all patients received some form of medication adherence or disease education associated with problem detection and resolution. Patient satisfaction levels with the service were very high.
引用
收藏
页码:471 / 483
页数:13
相关论文
共 20 条
[1]  
*AM PHARM ASS, 2006, APHAS SURV MED D
[2]  
*AM PHARM ASS, 2004, MON AM PHARM ASS, V2
[3]   Definition of medication therapy management: Development of professionwide consensus [J].
Bluml, Benjamin M. .
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2005, 45 (05) :566-572
[4]  
Carter Barry L, 2003, J Am Pharm Assoc (Wash), V43, P24, DOI 10.1331/10865800360467015
[5]  
Carter BL, 1997, PHARMACOTHERAPY, V17, P1274
[6]  
CHRISTENSEN DB, 2000, J AM PHARM ASSOC, V41, P609
[7]   Propensity score-matching methods for nonexperimental causal studies [J].
Dehejia, RH ;
Wahba, S .
REVIEW OF ECONOMICS AND STATISTICS, 2002, 84 (01) :151-161
[8]   Comprehensive medication therapy management: Identifying and resolving drug-related issues in a community pharmacy [J].
Doucette, WR ;
McDonough, RP ;
Klepser, D ;
McCarthy, R .
CLINICAL THERAPEUTICS, 2005, 27 (07) :1104-1111
[9]   EFFECTS OF MISSPECIFICATION OF THE PROPENSITY SCORE ON ESTIMATORS OF TREATMENT EFFECT [J].
DRAKE, C .
BIOMETRICS, 1993, 49 (04) :1231-1236
[10]   Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: The IMPROVE study [J].
Ellis, SL ;
Carter, BL ;
Malone, DC ;
Billups, SJ ;
Okano, GJ ;
Valuck, RJ ;
Barnette, DJ ;
Sintek, CD ;
Covey, D ;
Mason, B ;
Jue, S ;
Carmichael, J ;
Guthrie, K ;
Dombrowski, R ;
Geraets, DR ;
Amato, M .
PHARMACOTHERAPY, 2000, 20 (12) :1508-1516